A novel score predicts mortality after transjugular intrahepatic portosystemic shunt : MOTS - Modified TIPS Score

© 2022 The Authors. Liver International published by John Wiley & Sons Ltd..

BACKGROUND AND AIMS: The high risk for severe shunting-related post-interventional complications demands a stringent selection of candidates for transjugular intrahepatic portosystemic shunt (TIPS). We aimed to develop a simple and reliable tool to accurately predict early post-TIPS mortality.

METHODS: 144 cases of TIPS implantation were retrospectively analysed. Using univariate and multivariate Cox regression analysis of factors predicting mortality within 90 days after TIPS, a score integrating urea, international normalized ratio (INR) and bilirubin was developed. The Modified TIPS-Score (MOTS) ranges from 0 to 3 points: INR >1.6, urea >71 mg/dl and bilirubin >2.2 mg/dl account for one point each. Additionally, MOTS was tested in an external validation cohort (n = 187) and its performance was compared to existing models.

RESULTS: Modified TIPS-Score achieved a significant prognostic discrimination reflected by 90-day mortality of 8% in patients with MOTS 0-1 and 60% in patients with MOTS 2-3 (p < .001). Predictive performance (area under the curve) of MOTS was accurate (c = 0.845 [0.73-0.96], p < .001), also in patients with renal insufficiency (c = 0.830 [0.64-1.00], p = .02) and in patients with refractory ascites (c = 0.949 [0.88-1.00], p < .001), which are subgroups with particular room for improvement of post-TIPS mortality prediction. The results were reproducible in the validation cohort.

CONCLUSIONS: Modified TIPS-Score is a novel, practicable tool to predict post-TIPS mortality, that can significantly simplify clinical decision making. Its practical applicability should be further investigated.

Errataetall:

CommentIn: Liver Int. 2022 Jul;42(7):1700-1701. - PMID 35593018

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:42

Enthalten in:

Liver international : official journal of the International Association for the Study of the Liver - 42(2022), 8 vom: 02. Aug., Seite 1849-1860

Sprache:

Englisch

Beteiligte Personen:

Fürschuß, Luisa [VerfasserIn]
Rainer, Florian [VerfasserIn]
Effenberger, Maria [VerfasserIn]
Niederreiter, Markus [VerfasserIn]
Portugaller, Rupert H [VerfasserIn]
Horvath, Angela [VerfasserIn]
Fickert, Peter [VerfasserIn]
Stadlbauer, Vanessa [VerfasserIn]

Links:

Volltext

Themen:

8W8T17847W
Bilirubin
Hepatic encephalopathy
Journal Article
Mortality
Prediction
RFM9X3LJ49
Renal insufficiency
Risk
Transjugular intrahepatic portosystemic shunt
Urea

Anmerkungen:

Date Completed 25.07.2022

Date Revised 14.02.2024

published: Print-Electronic

ClinicalTrials.gov: NCT03459378

CommentIn: Liver Int. 2022 Jul;42(7):1700-1701. - PMID 35593018

Citation Status MEDLINE

doi:

10.1111/liv.15236

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM337920443